| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | -$68K | -101.5% |
| R&D Expense | $70.5M | -5.4% |
| SG&A Expense | $17.1M | +11.2% |
| Operating Income | -$87.7M | +9.5% |
| Interest Expense | $8K | +41.4% |
| Pre-tax Income | -$84.9M | +12.5% |
| Income Tax | -$197K | — |
| Net Income | -$84.7M | +12.7% |
| EPS (Basic) | -$1.81 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $111.1M | -41.6% |
| Short-term Investments | $73.8M | — |
| Current Assets | $192.8M | -5.5% |
| Total Assets | $206.9M | -5.5% |
| Current Liabilities | $17.1M | -6.7% |
| Long-term Debt | $4.6M | +215.0% |
| Total Liabilities | $21.6M | +9.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$62.6M | +20.0% |
| Capital Expenditures | $126K | -99.0% |
| Investing Cash Flow | -$73.4M | -183.9% |
| Financing Cash Flow | $56.8M | -12.8% |
| Free Cash Flow | -$62.7M | +30.6% |
| +23.0% |
| EPS (Diluted) | -$1.81 | +23.0% |
| Stockholders' Equity |
| $185.3M |
| -7.0% |